Better Healthcare ETF: VanEck's Biotech-Focused BBH vs. State Street's XPH Targeting Pharma
Alpha Vantage · The Motley Fool · · AI-summarised by FinFlash
This article compares two healthcare ETFs: VanEck Biotech ETF (BBH) and State Street SPDR S&P Pharmaceuticals ETF (XPH). While both target the healthcare sector with identical expense ratios, BBH offers concentrated exposure to large-cap biotech leaders, aiming for high growth and accepting more volatility, whereas XPH provides broader, more diversified access to the pharmaceutical industry, appealing to conservative investors.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.